TET2 exon 2 skipping is an independent favorable prognostic factor for cytogenetically normal acute myelogenous leukemia (AML): TET2 exon 2 skipping in AML.
| Image |  |
|---|---|
| Description | scientific article published on 16 January 2017 |
| Author/s |
author: Catherine Koering Aminetou Mint Mohamed Denis Guyotat Marie Balsat Lydia Campos Françoise Solly Didier Auboeuf Charles Dumontet Pascale Flandrin-Gresta Delphine Maucort-Boulch Meyling H Cheok Mauricette Michallet Olivier Nibourel Franck Mortreux Nicolas Boissel Franck E Nicolini Eric Wattel Sandrine Hayette Claude Preudhomme Isabelle Tigaud |
| Publication date | January 16, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |